Back to today’s briefing

Story perspectives

China's Generic Drug Crisis: Trust Erodes Amid Cost Cuts

2/12/2025

40 7

Summary

Story summary

In China, a viral interview with Dr. Zheng Minhua has sparked alarm over the quality of generic drugs, revealing flaws in the drug procurement system. While the system has saved over $50 billion since 2018, the low prices have led to rising fears of counterfeit and ineffective medications, eroding public trust and igniting urgent calls for reform.

History

Historical Context

Dr. Zheng Minhua's interview highlights flaws in China's generic drug procurement system, echoing historical concerns about drug quality. In the 1950s, China faced a severe opium crisis, prompting government crackdowns on narcotics. Despite initial successes, issues resurfaced in the 1980s, reflecting ongoing challenges in balancing affordability and safety in healthcare, similar to today's urgent calls for reform in drug quality.

1 of 2

Story summary

In China, a viral interview with Dr. Zheng Minhua has sparked alarm over the quality of generic drugs, revealing flaws in the drug procurement system. While the system has saved over $50 billion since 2018, the low prices have led to rising fears of counterfeit and ineffective medications, eroding public trust and igniting urgent calls for reform.

1 / 2